Harel Insurance Investments & Financial Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,070
Closed -$28K 438
2016
Q3
$28K Hold
1,070
﹤0.01% 277
2016
Q2
$24K Sell
1,070
-180
-14% -$4.28K ﹤0.01% 438
2016
Q1
$27K Sell
1,250
-1,250
-50% -$28.6K ﹤0.01% 253
2015
Q4
$79K Buy
+2,500
New +$76.6K 0.01% 167

Other funds holding SBIO

Harel Insurance Investments & Financial Services's SBIO Position: Q4 2016 in Review

Harel Insurance Investments & Financial Services sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2016, closing a stake of 1,070 shares — an estimated $28K sold.

Harel Insurance Investments & Financial Services first reported a position in SBIO in Q4 2015 and held it in 4 quarters. The position peaked at $79K in Q4 2015. 26 funds tracked by Wall St. Rank hold SBIO as of Q4 2016.

  • Harel Insurance Investments & Financial Services reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2016 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 1,070 ALPS Medical Breakthroughs ETF shares in Q4 2016, an estimated $28K.
  • Harel Insurance Investments & Financial Services first reported a position in ALPS Medical Breakthroughs ETF in Q4 2015 and held it in 4 quarters.
  • Harel Insurance Investments & Financial Services's ALPS Medical Breakthroughs ETF position peaked at $79K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2016.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2016, filed 6 Feb 2017.